The ACME Laboratories Ltd.'s latest marketcap:
As of 07/05/2025, The ACME Laboratories Ltd.'s market capitalization has reached $125.71 M. According to our data, The ACME Laboratories Ltd. is the 23157th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 125.71 M |
| Revenue (ttm) | 282 M |
| Net Income (ttm) | 19.5 M |
| Shares Out | 211.6 M |
| EPS (ttm) | 0.09 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 11/21/2024 |
| Earnings Date | 10/22/2025 |
The ACME Laboratories Ltd.'s yearly market capitalization.
| Date | Market Cap(BDT) | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | 125.71 M | -2.53% | 23157 |
| 12/30/2024 | 15.89 B | -11.65% | 21553 |
| 12/28/2023 | 17.99 B | 0% | 20025 |
| 12/29/2022 | 17.99 B | -1.73% | 18866 |
| 12/30/2021 | 18.3 B | 15.8% | 18422 |
| 12/30/2020 | 15.81 B | 22.66% | 17173 |
| 12/30/2019 | 12.89 B | -29.1% | 16066 |
| 12/27/2018 | 18.18 B | -24.65% | 13521 |
| 12/28/2017 | 24.12 B | 15.15% | 13026 |
| 12/29/2016 | 20.95 B | 11701 |
Company Profile
About ACME Laboratories Ltd.
ACME Laboratories Ltd. is a leading pharmaceutical company based in Bangladesh, specializing in the manufacture, marketing, and distribution of generic pharmaceutical formulations. Established in 1954 and headquartered in Dhaka, the company serves both domestic and international markets.
Product Portfolio
ACME Laboratories offers a diverse range of pharmaceutical products across multiple therapeutic categories, including:
- Allergic disorders, analgesics, and antifibrinolytics
- Anti-infectives, antivirals, and cardiovascular treatments
- Central nervous system (CNS) and diabetes medications
- Eye care, gastrointestinal, and respiratory solutions
- Hormones, steroids, and vitamins/minerals
- Ayurvedic, herbal, and nutraceutical products
Dosage Forms
The company provides medications in various forms, catering to human, veterinary, and herbal needs:
- Human Drugs: Tablets, capsules, syrups, creams, injections, inhalers, and more.
- Veterinary Drugs: Bolus, liquids, injections, and water-soluble powders.
- Herbal Products: Liquids, capsules, tablets, and ointments.
With a strong presence in Bangladesh and export operations, ACME Laboratories continues to expand its reach in the pharmaceutical industry.
Frequently Asked Questions
-
What is The ACME Laboratories Ltd.'s (DSE-ACMELAB) current market cap?As of 07/05/2025, The ACME Laboratories Ltd. (including the parent company, if applicable) has an estimated market capitalization of $125.71 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does The ACME Laboratories Ltd. (DSE-ACMELAB) rank globally by market cap?The ACME Laboratories Ltd. global market capitalization ranking is approximately 23157 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.